StockWatch
·
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Management ChangeJun 16, 2026, 08:31 AM

Nuwellis Appoints Mike McCormick as CEO; John Erb Becomes Chairman

AI Summary

Nuwellis, Inc. announced the appointment of Mike McCormick as its new Chief Executive Officer, effective June 30, 2026. Current President, CEO, and Chairman, John Erb, will transition from his executive leadership role but will continue to serve as Chairman of the Board. McCormick, a seasoned medical technology executive with over three decades of experience, previously served on Nuwellis's Board and is expected to lead the company into its next phase of growth, focusing on commercial execution and pipeline advancement.

Key Highlights

  • Mike McCormick appointed Chief Executive Officer of Nuwellis.
  • Appointment is effective June 30, 2026.
  • John Erb transitions from President & CEO to continue as Chairman of the Board.
  • McCormick previously served as a Board Member and Independent Director of Nuwellis from June 2023 to January 2026.
  • McCormick brings over three decades of leadership experience in medical technology.